UBS AM’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Buy |
408,902
+107,352
| +36% | +$371K | ﹤0.01% | 2289 |
|
|
2025
Q1 | $790K | Buy |
301,550
+68,968
| +30% | +$181K | ﹤0.01% | 2396 |
|
|
2024
Q4 | $958K | Buy |
232,582
+9,293
| +4% | +$38.3K | ﹤0.01% | 2378 |
|
|
2024
Q3 | $1.58M | Buy |
223,289
+13,640
| +7% | +$96.6K | ﹤0.01% | 2166 |
|
|
2024
Q2 | $1.37M | Sell |
209,649
-347,647
| -62% | -$2.27M | ﹤0.01% | 2203 |
|
|
2024
Q1 | $4.63M | Sell |
557,296
-284,570
| -34% | -$2.36M | ﹤0.01% | 1285 |
|
|
2023
Q4 | $9.27M | Sell |
841,866
-23,589
| -3% | -$260K | ﹤0.01% | 1014 |
|
|
2023
Q3 | $7.28M | Sell |
865,455
-21,087
| -2% | -$177K | ﹤0.01% | 1064 |
|
|
2023
Q2 | $14.6M | Hold |
886,542
| – | – | 0.01% | 844 |
|
|
2023
Q1 | $14.6M | Buy |
886,542
+70,544
| +9% | +$1.16M | 0.01% | 844 |
|
|
2022
Q4 | $12.2M | Sell |
815,998
-13,562
| -2% | -$203K | 0.01% | 869 |
|
|
2022
Q3 | $18.6M | Buy |
829,560
+47,917
| +6% | +$1.07M | 0.01% | 779 |
|
|
2022
Q2 | $13.1M | Buy |
781,643
+207,196
| +36% | +$3.47M | 0.01% | 855 |
|
|
2022
Q1 | $17.2M | Sell |
574,447
-40,811
| -7% | -$1.22M | 0.01% | 881 |
|
|
2021
Q4 | $18.9M | Buy |
615,258
+381,012
| +163% | +$11.7M | 0.01% | 910 |
|
|
2021
Q3 | $7.39M | Sell |
234,246
-27,995
| -11% | -$883K | ﹤0.01% | 1206 |
|
|
2021
Q2 | $9.6M | Sell |
262,241
-163,210
| -38% | -$5.97M | ﹤0.01% | 1131 |
|
|
2021
Q1 | $14.7M | Sell |
425,451
-58,944
| -12% | -$2.04M | 0.01% | 957 |
|
|
2020
Q4 | $20.1M | Buy |
484,395
+229,886
| +90% | +$9.55M | 0.01% | 851 |
|
|
2020
Q3 | $10.8M | Buy |
+254,509
| New | +$10.8M | 0.01% | 925 |
|